Foresite Capital Management IV as of March 31, 2026
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 8 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 56.9 | $135M | 4.8M | 28.25 | |
| Cytokinetics (CYTK) | 14.0 | $33M | 503k | 65.91 | |
| Eikon Therapeutics | 8.7 | $21M | 1.9M | 10.58 | |
| Lyell Immunopharma (LYEL) | 6.8 | $16M | 800k | 20.06 | |
| Relay Therapeutics (RLAY) | 4.2 | $10M | 1.0M | 9.95 | |
| Xenon Pharmaceuticals (XENE) | 3.9 | $9.3M | 160k | 58.15 | |
| Alector (ALEC) | 3.5 | $8.4M | 3.9M | 2.15 | |
| Maze Therapeatics (MAZE) | 2.0 | $4.7M | 157k | 29.85 |
